<?xml version="1.0" encoding="UTF-8"?>
<ref id="B99-pharmaceuticals-13-00096">
 <label>99.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Cohen</surname>
    <given-names>J.A.</given-names>
   </name>
   <name>
    <surname>Chun</surname>
    <given-names>J.</given-names>
   </name>
  </person-group>
  <article-title>Mechanisms of fingolimodâ€™s efficacy and adverse effects in multiple sclerosis</article-title>
  <source>Ann. Neurol.</source>
  <year>2011</year>
  <volume>69</volume>
  <fpage>759</fpage>
  <lpage>777</lpage>
  <pub-id pub-id-type="doi">10.1002/ana.22426</pub-id>
  <?supplied-pmid 21520239?>
  <pub-id pub-id-type="pmid">21520239</pub-id>
 </element-citation>
</ref>
